Other headlines:FDA clears perfusion software
The newest release of a web-based insurance eligibility verification tool developed by MedCurrent includes capabilities for imaging centers to automate insurance workflow, eliminate errors, reduce denied claims, speed collections, and improve cash flow. MedCurrent Verify connects to databases from more than 350 U.S.-based insurance carriers to secure real-time patient coverage information. Extending this capability to imaging centers will help centers improve claim submission accuracy and optimize reimbursement, according to MedCurrent. This specially developed version of Verify includes specialty templates that deliver radiology-specific eligibility information first, eliminating the need for time-consuming scrolling.
Prism Clinical Imaging has been cleared by the FDA to begin marketing a suite of brain perfusion software programs designed to make functional MRI, diffusion tensor imaging, and advanced physiological studies available in general clinical practice. One module, called Prism Acquire, addresses contrast injection, including preload, and acquisition of time course data on popular MR scanners using gradient-echo and/or spin-echo sequences. The second, Prism Process, provides model-free automatic time course analysis with patented algorithms for leakage correction. The third, Prism View, displays the resulting cerebral blood volume maps integrated with other functional and physiological information and makes them available for export to PACS, treatment planning, and neuronavigation systems.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.